{
    "code": "02011613",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02011613",
    "time": "2020-02-25 09:56:59",
    "許可證字號": "衛署藥輸字第011613號",
    "註銷狀態": "已註銷",
    "註銷日期": "77\/03\/21",
    "註銷理由": "移轉（申請商）",
    "製造許可登錄編號": "",
    "有效日期": "77\/07\/21",
    "發證日期": "72\/07\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201161301",
    "中文品名": "泰福治膠囊２００公絲",
    "英文品名": "TEFSIEL C",
    "適應症": "消化器癌（胃癌、結腸癌、直腸癌等）乳癌、肺癌自覺的、他覺的症狀的緩解",
    "劑型": "130膠囊劑",
    "包裝": "盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "TEGAFUR (FTORAFUR)",
    "限制項目": "02輸　入",
    "申請商名稱": "1307201100  萬象股份有限公司",
    "申請商地址": "台北巿延平南路６１號４０５室",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0419000  TOWA PHARMACEUTICAL CO., LTD.",
            "製造廠廠址": "2-23 KAMITANOYUCHO,BEPPU CITY DOITA PREFECTURE2-11 SHINBASH-CHO, KADOMA CITY OSAKA JAPAN",
            "製造廠公司地址": "2-11 SHINBASH-CHO, KADOMA CITY OSAKA JAPAN",
            "製造廠國別": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1008400300",
            "成分名稱": "TEGAFUR (FTORAFUR)",
            "含量描述": "200",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ]
}